Novartis Pharma Schweiz AG：

Please note that on October 10, 2026, CDI sent the Notification of Drug Oversea Inspection Results of Basiliximab for Injection to the agency of the medicine in China.

If there are any questions, please do not hesitate to contact us as soon.

Contact: Ping Zhang

Tel.+86 010 68441691

Center for Drug Inspection of NMPA
October 10, 2026